IMVT R&D Expense Growth
Immunovant Inc · R&D Expense Growth
IMVT R&D Expense Growth
Latest reported26.53%period ending
IMVT FY R&D Growth (YoY) (0.00% → 26.53%)
Latest values, visible window
High-resolution chart · PNG
IMVT r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 26.5277% | |
| 69.5019% | |
| 32.8666% | |
| 57.411% | |
| 48.3995% | |
| 43.1427% | |
| 86.2472% | |
| -80.9756% | |
| 0% |